Publications:

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.

Leukemia & Lymphoma

Pollyea, Daniel A DA; Kohrt, Holbrook E HE; Zhang, Bing B; Zehnder, James J; Schenkein, David D; Fantin, Valeria V; Straley, Kimberly K; Vasanthakumar, Aparna A; Abdel-Wahab, Omar O; Levine, Ross R; Godley, Lucy A LA; Medeiros, Bruno C BC

Publication Date: 2013-02

Variant appearance in text: TET2: S214X

PubMed Link: 22680765

Variant Present in the following documents:

• Main text

View BVdb publication page